0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
News From the Food and Drug Administration  | 
Fluconazole Under Review
Rebecca Voelker, MSJ
JAMA Dermatology
Research Letter  | 
Association of CYP2C19 *17/*17 Genotype With the Risk of Voriconazole-Associated Squamous Cell Carcinoma
Kiyanna Williams, BS; Sarah T. Arron, MD, PhD
JAMA Ophthalmology
Brief Report  | 
Changing Azole Resistance A Secondary Analysis of the MUTT I Randomized Clinical Trial
N. Venkatesh Prajna, MD; Prajna Lalitha, MD; Revathi Rajaraman, MD; et al.
JAMA Dermatology
Observation  | 
Phaeoacremonium sphinctrophorum as a Novel Agent of Eumycetoma
Beatriz Bustamante, MD; Sarah Abdalla Ahmed, PhD; G. S. De Hoog, PhD; et al.